Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Apr 21:27:e00206.
doi: 10.1016/j.crwh.2020.e00206. eCollection 2020 Jul.

Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report

Cristina Llaneza-Suarez  1 , Montserrat Eiriz-Eirin  1 , Placido Llaneza  2
Affiliations
Case Reports

Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report

Cristina Llaneza-Suarez et al. Case Rep Womens Health. .

Abstract

Patients with surgical menopause often present to their primary care provider with menopausal symptoms. Here we present an unusual case of palmar arch artery occlusion in a 55-year-old woman with primary Raynaud's disease taking oral combined menopausal hormone therapy after surgical menopause for endometriosis. She was successfully treated with intravenous infusion of prostaglandin E1 and nitroglycerin patches over two weeks. Menopausal hormone therapy was stopped and her vasomotor symptoms did not recur.

Keywords: Arterial palmar arch occlusion; Cardiovascular risk; Finger vascular lesion; Menopausal hormone therapy; Raynaud's disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Right-hand arteriography showing narrowing and tapering of radial, ulnar, interosseous arteries and digital vessels and occlusion of the palmar arch (arrow).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Rodriguez M., Shoupe D. Endocrinology and Metabolism Clinics of North America. W.B. Saunders; 2015. Surgical menopause; pp. 531–542. September 1. - PubMed
    1. Finch A., Narod S.A. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: a review. Maturitas. 2011:261–265. November. - PubMed
    1. Neves-E-Castro M., Birkhauser M., Samsioe G., Lambrinoudaki I., Palacios S., Borrego R.S., Llaneza P., Ceausu I., Depypere H., Erel C.T. EMAS position statement: the ten point guide to the integral management of menopausal health. Maturitas. 2015;81(1) - PubMed
    1. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A.A., Howard B.V., Johnson K.C. Risks and benefits of Estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333. - PubMed
    1. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of Estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–613. - PubMed

Publication types

LinkOut - more resources